BFAM vs CHH

BFAM exhibits a mixed financial profile with a weak Piotroski F-Score of 4/9 indicating marginal financial health, and no available Altman Z-Score limits distress risk assessment. Despite strong recent earnings growth (YoY EPS +45.7%) and solid revenue momentum (11.6% growth), the company faces significant liquidity concerns with a current ratio of 0.54 and quick ratio of 0.43, suggesting near-term solvency risks. Valuation is stretched relative to Graham’s defensive standard ($44.17 vs current $93.43), though growth investors may justify the premium given robust earnings progression and analyst target of $127.33. Insider selling activity and bearish technical trend counterbalance strong profitability metrics like ROE of 14.19% and improving margins.

The company exhibits significant financial fragility, evidenced by a weak Piotroski F-Score of 3/9 and a precarious Debt/Equity ratio of 11.16. Valuation is severely stretched, with the current price of $119.07 trading at a massive premium to both the Graham Number ($26.45) and the Intrinsic Value ($54.81). While profit margins remain high, negative earnings growth (-13.6% YoY) and poor liquidity (Current Ratio 0.87) signal operational distress. Combined with bearish insider activity and a 0/100 technical trend, the risk-reward profile is highly unfavorable.